Professor Richard Conway

Richard Conway, MB BCh BAO PhD, is a rheumatologist and general physician working in St. James's Hospital, a Fellow of the Royal College of Physicians of Ireland, and a Clinical Lecturer in Trinity College, working in the School of Medicine. He has a PhD in clinical and translational aspects of giant cell arteritis from University College Dublin. Dr Conway has over 100 peer-reviewed research publications. His research focuses on vasculitis, interstitial lung disease in rheumatic diseases, and on outcomes research in acute medicine. He is the author of chapters in three editions of Kumar and Clark's Clinical Medicine, the definitive textbook for undergraduate and postgraduate medical teaching. He sits on the editorial board of EMJ Rheumatology and the Advisory Board of Rheumatology and Therapy. Dr Conway is the National Lead for the COVID-19 Global Rheumatology Alliance and sits on the Clinical and Scientific Committee of this organisation. He is a member of the Outcome Measures in Rheumatology (OMERACT) Polymyalgia Rheumatica (PMR) Working Group and the Working Group on Training in Rheumatology across Europe. He is a member of the European League Against Rheumatism (EULAR) Strategy 2023 Working Group on Quality of Care and the EULAR Education Sub-committee (Training/CME), and a previous member of the Emerging EULAR network (EMEUNET) leadership committee and leader of the EMEUNET newsletter subgroup. He is a member of the EULAR-EMEUNET Journal Club Core Team. Dr Conway was a member of the EULAR Task Force on developing 2016 update of the EULAR recommendations for the management of early arthritis and is currently a member of EULAR's task force for the update of SARS-CoV-2 recommendations. He has been the lead on numerous clinical committees including the Physician Assistant Introduction Programme in Blackrock Clinic and the St. James Hospital NCHD Committee, and is the current Secretary of the Irish Society for Rheumatology Private Practice Committee. Dr Conway received numerous awards during his undergraduate career, and subsequently received the Young Investigator Award of the Irish Society for Rheumatology (2017) and was the Overall Winner of the HSE Open Access Research Awards (2016), as well as receiving awards for best oral and poster presentations from the Irish Society for Rheumatology on a number of occasions. Dr Conway is passionate about educating the next generation of physicians as well as mentoring aspiring clinician researchers. He believes in the power of collaborative research endeavours on an international scale, as evidenced by his ongoing collaborations in vasculitis and COVID-19 research. He lives in Dublin with his wife and children.

  INTERSTITIAL LUNG-DISEASE   METHOTREXATE   RHEUMATOID ARTHRITIS   Rheumatology   Scleroderma   SYSTEMIC VASCULITIS   TEMPORAL ARTERITIS   VASCULITIS

I am a rheumatologist and epidemiologist with interests in vasculitis, polymyalgia rheumatica, early arthritis, interstitial lung disease in rheumatic diseases, acute medical admissions and outcomes. I have established a prospective longitudinal observational study of polymyalgia rheumatica and giant cell arteritis in St. James's Hospital. As part of this project blood and tissue samples are utilised for translational research work. This work follows on from my work on a large giant cell arteritis registry during my time in St. Vincent's University Hospital. I am a collaborator on multisite international studies in vasculitis, giant cell arteritis, and polymyalgia rheumatica. I have a strong interest in lung disease in rheumatic diseases, and in particular interstitial lung disease in this area. I have published extensively in this area mainly utilising systematic literature review and meta-analysis to clarify issues around drug safety in this setting. I am part of the acute medicine research group in St. James's Hospital and we have published extensively on outcomes and prognostic factors in acute medical admissions. Finally, during the COVID-19 pandemic I have been the Irish national lead and a member of the clinical and scientific committee for the Global Rheumatology Alliance, an international collaborative project exploring outcomes in patients with rheumatic diseases during the pandemic as well as many other topics related to the impact of the pandemic on rheumatology.